在公共抗体的轻链驱动亲和力成熟的融合和克隆型丰富突变
Vishal Rao1,2,3, Iden Sapse1,3, Hallie Cohn1,2
1Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
bioRxiv : the preprint server for biology
|March 31, 2025
概括
识别公共抗体中的特定突变可以指导疫苗设计. 这项研究发现,公开的抗体克隆类型中的丰富突变增强了抗原结合,为疫苗开发提供了新的框架.
科学领域:
- 免疫学 免疫学 免疫学
- 疫苗学 疫苗学 疫苗学
背景情况:
- 识别保存表位的公共抗体对于有效的疫苗开发至关重要.
- 识别改善抗原亲和力的体质突变 (SHM) 是提高疫苗疗效的关键.
研究的目的:
- 为了确定增强亲和力的SHM是否有选择性地富含公共抗体克隆类型.
- 开发一个框架来识别这些关键的SHM,以指导疫苗设计.
主要方法:
- 使用人类IGHV4-59/IGKV3-20公共抗体作为模型系统.
- 在公共抗体和具有相似V基因但具有不同表位特异性的抗体之间比较了SHM特征.
- 分析突变模式以识别克隆型丰富突变.
主要成果:
- 在模型抗体的光链内识别了克隆型丰富突变.
- 证明这些结合的SHM增强了与新型病毒表位体的结合.
- 在多次接种疫苗后观察到对该表位的抗体反应增加.
结论:
- 建立了一个基于融合和克隆型丰富的基因基因基因基因基因基因基因基因基因鉴定框架.
- 这种方法可以帮助设计引发保护性公共抗体反应的疫苗.
相关概念视频
Hybridoma Technology
13.8K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
13.8K
Affinity and Avidity
35.7K
Overview
35.7K
T Cell Activation and Clonal Selection
596
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
596
Antibody Structure and Classes
703
Antibodies, also known as immunoglobulins, are produced by B cells in response to foreign substances, such as bacteria and viruses. These proteins are critical for recognizing and neutralizing these substances, protecting the body from potential harm.
The basic structure of an antibody consists of four protein chains: two identical heavy chains and two identical light chains. These chains are held together by disulfide bonds and other non-covalent interactions, forming a Y-shaped structure.
The basic structure of an antibody consists of four protein chains: two identical heavy chains and two identical light chains. These chains are held together by disulfide bonds and other non-covalent interactions, forming a Y-shaped structure.
703
B Cell Activation and Differentiation
1.3K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
1.3K
Antibody Structure
58.6K
Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
58.6K


